Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs

Wednesday, June 5, 2019 1 min read

Key Takeaway: Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs

Full Press Release Details

Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs.